drugset / Trial / NCT01938183

Full-mouth Periodontal Debridement and Metronidazole Gel in Patients With Chronic Periodontitis

NCT01938183

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Hypothesis: metronidazole gel applied topically after periodontal debridement in smokers volunteers could improve clinical parameters when compared to metronidazole tablets + periodontal debridement. Method: 30 smokers with chronic periodontitis were randomly assigned into 3 groups: periodontal debridement combined with 3 g placebo gel; periodontal debridement combined with daily topical application of 3 g metronidazole benzoate gel (15%); and periodontal debridement combined with a daily single dose of 750 mg metronidazole. Clinical parameters evaluated were visible plaque, gingival bleeding, probing pocket depth and relative attachment level.

Timeline

Start
2006-11
Primary completion
2010-03
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 750 mg Oral
Comparator Metronidazole Small molecule 3 g Oral

Indications